Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lanzhou Taibao Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and Western pharmaceuticals. Established in 1989 as a joint venture, the company is based in Lanzhou, Gansu Province, and has become a leading exporter of TCM products to international markets, including Southeast Asia, North America, and Europe. Its product portfolio features over 100 varieties of concentrated pills, tablets, and capsules, with flagship products like Xiao Yao Wan and Liu Wei Di Huang Wan. The company operates modern GMP-certified manufacturing facilities and emphasizes the modernization of traditional herbal formulas. Lanzhou Taibao leverages the rich natural herbal resources of the Gansu region to maintain a competitive edge in raw material sourcing and product efficacy. As a subsidiary of Lanzhou Foci Pharmaceutical, it benefits from a strong heritage in TCM modernization and large-scale industrial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lanzhou Taibao Pharmaceutical.